Eisai Pulls Another Leqembi Growth Lever With First Subcutaneous Approval

List Price Is $375 Per Dose, $19,500 Annually

 
• By Mandy Jackson
  
Subcutaneous Leqembi could ease the treatment burden for Alzheimer's patients and health care providers (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapy Areas